Literature DB >> 28181622

A framework for multi-scale simulation of crystal growth in the presence of polymers.

Taraknath Mandal1, Wenjun Huang1, Jodi M Mecca2, Ashley Getchell2, William W Porter3, Ronald G Larson1.   

Abstract

We present a multi-scale simulation method for modeling crystal growth in the presence of polymer excipients. The method includes a coarse-grained (CG) model for small molecules of known crystal structure whose force field is obtained using structural properties from atomistic simulations. This CG model is capable of stabilizing the molecular crystal structure and capturing the crystal growth from the melt for a wide range of small organic molecules, as demonstrated by application of our method to the molecules isoniazid, urea, sulfamethoxazole, prilocaine, oxcarbazepine, and phenytoin. This CG model can also be used to study the effect of additives, such as polymers, on the inhibition of crystal growth by polymers, as exemplified by our simulation of suppression of the rate of crystal growth of phenytoin, an active pharmaceutical ingredient (API), by a cellulose excipient, functionalized with acetate (Ac), hydroxy-propyl (Hp) and succinate (Su) groups. We show that the efficacy of the cellulosic polymers in slowing crystal growth of small molecules strongly depends on the functional group substitution on the cellulose backbone, with the acetate substituent group slowing crystal growth more than does the deprotonated succinate group, which we confirm by experimental drug supersaturation studies.

Entities:  

Year:  2017        PMID: 28181622     DOI: 10.1039/c6sm02893d

Source DB:  PubMed          Journal:  Soft Matter        ISSN: 1744-683X            Impact factor:   3.679


  2 in total

1.  Unravelling the effects of size, volume fraction and shape of nanoparticle additives on crystallization of nanocomposite polymers.

Authors:  Ahmad Jabbarzadeh; Beny Halfina
Journal:  Nanoscale Adv       Date:  2019-10-17

Review 2.  Automation and data-driven design of polymer therapeutics.

Authors:  Rahul Upadhya; Shashank Kosuri; Matthew Tamasi; Travis A Meyer; Supriya Atta; Michael A Webb; Adam J Gormley
Journal:  Adv Drug Deliv Rev       Date:  2020-11-24       Impact factor: 15.470

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.